Target intelligence / Profile preview

Lung ventilation

Molecular classification
Other
01

Overview

Lung ventilation, or pulmonary ventilation, is the physiological process of air exchange between the environment and the lung alveoli, essential for oxygen uptake and carbon dioxide removal (StatPearls, NBK482414). It is driven by pressure gradients created by the contraction and relaxation of respiratory muscles, primarily the diaphragm and intercostal muscles, under the control of the autonomic nervous system (NIH SEER Training). Although lung ventilation is a physiological process rather than a specific molecular target, it is the primary functional outcome measured in the treatment of respiratory diseases. Pharmacological intervention typically targets specific receptors, such as beta-2 adrenergic or muscarinic receptors, to alter airway caliber and improve airflow (PubMed, PMC4517537). Clinical management of ventilation is crucial in conditions like asthma, COPD, and acute respiratory failure, where mechanical or pharmacological support may be required to maintain life-sustaining gas exchange. Drugs like albuterol act as bronchodilators to increase ventilation, while others like opioids can cause dangerous respiratory depression. Monitoring ventilation involves measuring parameters such as tidal volume and respiratory rate to ensure adequate gas exchange. In critical care, mechanical ventilation is used to assist or replace spontaneous breathing when the patient's own ventilatory capacity is insufficient.

Other names
Pulmonary ventilationBreathingExternal respirationMinute ventilationTidal breathing
02

Mechanism of action

Modulation of airway resistance via bronchodilation, alteration of central respiratory drive in the medulla, or mechanical assistance of gas exchange.

03

Biological functions

Gas exchangeAcid-base homeostasisOxygenationCarbon dioxide eliminationOther
04

Disease associations

Chronic obstructive pulmonary disease (COPD)AsthmaRespiratory failureSleep apneaAcute respiratory distress syndrome (ARDS)Other
05

Safety considerations

Respiratory depressionHypoventilationHypercapniaHypoxiaBarotraumaVentilator-induced lung injury (VILI)
06

Interacting drugs

Albuterol

9 more in the full profile.

07

Biomarkers

Forced expiratory volume in 1 second (FEV1)Peak expiratory flow (PEF)Partial pressure of carbon dioxide (PaCO2)Oxygen saturation (SpO2)Tidal volume (VT)

Beyond the preview

Go deeper on Lung ventilation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lung ventilation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call